eprintid: 10189080 rev_number: 11 eprint_status: archive userid: 699 dir: disk0/10/18/90/80 datestamp: 2024-03-15 10:20:32 lastmod: 2024-05-13 13:05:43 status_changed: 2024-03-15 10:20:32 type: article metadata_visibility: show sword_depositor: 699 creators_name: Giganti, Francesco creators_name: Gupta, Rajan T title: Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA? ispublished: inpress divisions: UCL divisions: B02 divisions: C10 divisions: D16 keywords: cost effectiveness, multiparametric prostate MRI, Prostate cancer note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. date: 2024-02-14 date_type: published publisher: American Roentgen Ray Society official_url: http://dx.doi.org/10.2214/ajr.24.30973 full_text_type: other language: eng verified: verified_manual elements_id: 2248141 doi: 10.2214/AJR.24.30973 medium: Print-Electronic lyricists_name: Giganti, Francesco lyricists_id: FGIGA51 actors_name: Giganti, Francesco actors_id: FGIGA51 actors_role: owner full_text_status: restricted publication: American Journal of Roentgenology event_location: United States issn: 0361-803X citation: Giganti, Francesco; Gupta, Rajan T; (2024) Beyond the AJR: Can Prostate MRI and MRI-Guided Biopsy Be Cost-Effective in the United States in Patients With Elevated PSA? American Journal of Roentgenology 10.2214/AJR.24.30973 <https://doi.org/10.2214/AJR.24.30973>. (In press). document_url: https://discovery.ucl.ac.uk/id/eprint/10189080/1/giganti-gupta-2024-beyond-the-ajr-can-prostate-mri-and-mri-guided-biopsy-be-cost-effective-in-the-united-states-in.pdf